CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Businesses  /  Generics  /  Quality & Compliance

QUALITY & COMPLIANCE

Quality & Compliance

At Biocon, excellence is our hallmark and a value. Quality and Compliance enable us to consistently achieve this throughout the product lifecycle. We follow Good Manufacturing Practices, Good Laboratory Practices, Good Documentation Practices, and Good Distribution Practices throughout our operations to assure high standards of quality and compliance.

Over 850+ highly skilled Quality professionals oversee our development and manufacturing processes, ensuring strict adherence to current Good Manufacturing Practices (cGMPs). Their relentless focus guarantees that every product meets internationally recognized standards of Quality, Efficacy, and Safety, upholding our commitment to global compliance and patient well-being

null
MAINTAINING COMPLIANCE
Our manufacturing sites have undergone several regulatory inspections by health authorities across the world as a part of new product approval, and/or verification of compliance. This ensures continued global acceptance of our complex small molecule Active Pharmaceutical Ingredients, Biosimilars and Oral solid dosage formulations.

Proactive investments in infrastructure, training and certifications have helped us maintain a strong compliance track record in regulatory inspections.

null
MEETING QUALITY STANDARDS
Our best-in-class technology and processes meet the demanding benchmarks of global regulatory agencies. Our manufacturing facilities across Bengaluru, Hyderabad, Visakhapatnam in India, and Johor in Malaysia have received over 125+ cGMP approvals from international regulatory agencies. Biocon has a new manufacturing facility in Cranbury, New Jersey, US, which was inaugurated in September 2025.
Facilities Approved By Key International Regulatory Agencies
null
U.S. FDA
null
EMA
null
TGA, Australia
null
PMDA, Japan
null
Health Canada
null
MCC, South Africa
null
ANVISA, Brazil
null
COFEPRIS, Mexico
null
Ministry of Food and Drug Safety (MFDS), South Korea
null
Ministry of Health, Russia
null
NPRA, Ministry of Health, Malaysia
null
Ministry of Health, Turkey
null
SFDA
Siddharth Mittal
KEY MANAGEMENT TEAM
PRODUCTS
PRESS RELEASES
CORPORATE GOVERNANCE
R&D
WORKING WITH US
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>